[Postoperative follow-up in differentiated carcinoma of the thyroid gland].
Serial serum thyroglobulin determinations and 131I whole body scans are the main diagnostic tools in the follow-up study of patients with treated differentiated thyroid cancer. A thyroglobulin level below 1 ng/ml during suppressive therapy is unsuspicious . In two thirds of patients there is discordance of iodide trapping and thyroglobulin secretion: thyroglobulin assay can't therefore be used as a predictive index of radioiodine uptake.
D000230:Adenocarcinoma / Q000601:surgery*; D002277:Carcinoma / Q000601:surgery*; D002291:Carcinoma, Papillary / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D011182:Postoperative Care; D011877:Radionuclide Imaging; D013954:Thyroglobulin / Q000097:blood; D013963:Thyroid Hormones / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000601:surgery*; D013965:Thyroidectomy
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013954:Thyroglobulin
Follow-up post-operatorio dei carcinomi differenziati della tiroide.